.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Post-pancreatectomy diabetes, also known as type 3c diabetes, often complicates recovery after pancreatic surgery. Consequently, patients face extreme glycemic variability and a high risk of severe hypoglycemia. Automated glucose control systems, including fully closed-loop and bihormonal artificial pancreas technologies, represent a transformative approach to managing these challenges. These devices integrate continuous monitoring with real-time insulin adjustments to stabilize blood sugar.
Specifically, recent systematic reviews demonstrate that fully closed-loop systems significantly increase the time in range (TIR) for patients. Research shows TIR improvements from 41.1% with standard care to 77.7% with automated delivery. Furthermore, bihormonal systems can reduce the time spent in hypoglycemia to nearly 0%. Moreover, these technologies maintain improved glycemic control during long-term follow-up. This provides a safer environment for patients during the critical postoperative phase.
However, the implementation of these tools requires careful institutional planning and expert oversight. Additionally, simulation studies estimate that automated systems can reduce nursing workload by as much as 67%. Therefore, hospitals should focus on creating structured training programs and standardized protocols for staff. Although current evidence for continuous metrics remains low, the clinical benefits for preventing severe hypoglycemia are substantial. Ultimately, multi-center studies with larger samples will further confirm the cost-efficiency and long-term effectiveness of these advanced strategies.
Post-pancreatectomy diabetes, or type 3c diabetes, occurs after the surgical removal of part or all of the pancreas. It involves the loss of both insulin and glucagon-producing cells, leading to highly unstable blood sugar levels and an increased risk of severe hypoglycemia.
These systems automate insulin adjustments based on real-time sensor data. Consequently, they reduce the need for frequent manual blood glucose checks and dosage calculations, which can lower the nursing workload by over 60% in surgical wards.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Alaimo CG et al. Automated glucose control systems in post-pancreatectomy diabetes: systematic review of clinical efficacy and nursing care implications. Minerva Gastroenterol (Torino). 2026 Mar 09. doi: 10.23736/S2724-5985.26.04089-1. PMID: 41801256.
van Veldhuisen CL, Latenstein AEJ, Blauw H, et al. Bihormonal Artificial Pancreas With Closed-Loop Glucose Control vs Current Diabetes Care After Total Pancreatectomy: A Randomized Clinical Trial. JAMA Surg. 2022;157(11):950-957. doi:10.1001/jamasurg.2022.3702.
Krutkyte G, Roos J, Schuerch D, et al. Fully Closed-Loop Insulin Delivery in Patients Undergoing Pancreatic Surgery. Diabetes Technol Ther. 2023;25(3):206-211. doi:10.1089/dia.2022.0400.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Automated glucose control systems improve glycemic stability and reduce nursing workload in patients with post-pancreatectomy diabetes, a systematic review ...
6 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
